 | • レポートコード：B-GIR08C4352 • 出版社/出版日：GlobalInfoResearch / 2019年8月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、105ページ • 納品方法：Eメール • 産業分類：Pharma & Healthcare |
| Single User | ￥522,000 (USD3,480) | ▷ お問い合わせ |
| Corporate User | ￥1,044,000 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートは、ペンブロリズマブの世界市場について調べ、まとめました。種類別セグメントは、50ミリグラム注射、100ミリグラム注射等、用途別セグメントは、進行黒色腫、頭頸部扁平上皮癌（HNSCC）、切除不能、転移性固形腫瘍、その他等に区分しました。ペンブロリズマブの世界市場概観、企業動向、企業別ペンブロリズマブシェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。 ・ペンブロリズマブの市場概観 ・ペンブロリズマブの企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等） ・ペンブロリズマブの企業別販売動向、市場シェア、市場集中度、競争動向 ・ペンブロリズマブの世界市場規模 ・ペンブロリズマブの北米市場分析（アメリカ、カナダ、メキシコ等） ・ペンブロリズマブのアメリカ市場規模推移 ・ペンブロリズマブのカナダ市場規模推移 ・ペンブロリズマブのメキシコ市場規模推移 ・ペンブロリズマブのヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等） ・ペンブロリズマブのドイツ市場規模推移 ・ペンブロリズマブのイギリス市場規模推移 ・ペンブロリズマブのロシア市場規模推移 ・ペンブロリズマブのアジア太平洋市場分析（日本、中国、韓国、インド、東南アジア等） ・ペンブロリズマブの日本市場規模推移 ・ペンブロリズマブの中国市場規模推移 ・ペンブロリズマブの韓国市場規模推移 ・ペンブロリズマブのインド市場規模推移 ・ペンブロリズマブの東南アジア市場規模推移 ・ペンブロリズマブの南米市場分析（ブラジル、アルゼンチン等） ・ペンブロリズマブの中東・アフリカ市場分析（サウジアラビア、UAE、南アフリカ等） ・ペンブロリズマブの種類別分析/販売量、売上、市場シェア（50ミリグラム注射、100ミリグラム注射） ・ペンブロリズマブの用途別分析/市場規模（進行黒色腫、頭頸部扁平上皮癌（HNSCC）、切除不能、転移性固形腫瘍、その他） ・ペンブロリズマブの市場予測2019年-2024年（地域別予測、種類別予測、用途別予測） ・ペンブロリズマブの販売チャネル・代理店・貿易業者・ディーラー分析 |
Scope of the Report:
The worldwide market for Pembrolizumab is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study.
This report focuses on the Pembrolizumab in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Market Segment by Manufacturers, this report covers
Merck
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
50mg Injection
100mg Injection
Market Segment by Applications, can be divided into
Advanced Melanoma
Head and Neck Squamous Cell Carcinoma (HNSCC)
Unresectable or Metastatic Solid Tumor
Other
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Pembrolizumab product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Pembrolizumab, with price, sales, revenue and global market share of Pembrolizumab in 2017 and 2018.
Chapter 3, the Pembrolizumab competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Pembrolizumab breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, Pembrolizumab market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe Pembrolizumab sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Table of Contents
1 Market Overview
1.1 Pembrolizumab Introduction
1.2 Market Analysis by Type
1.2.1 50mg Injection
1.2.2 100mg Injection
1.3 Market Analysis by Applications
1.3.1 Advanced Melanoma
1.3.2 Head and Neck Squamous Cell Carcinoma (HNSCC)
1.3.3 Unresectable or Metastatic Solid Tumor
1.3.4 Other
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2014-2024)
1.4.1.2 Canada Market States and Outlook (2014-2024)
1.4.1.3 Mexico Market States and Outlook (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2014-2024)
1.4.2.2 France Market States and Outlook (2014-2024)
1.4.2.3 UK Market States and Outlook (2014-2024)
1.4.2.4 Russia Market States and Outlook (2014-2024)
1.4.2.5 Italy Market States and Outlook (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2014-2024)
1.4.3.2 Japan Market States and Outlook (2014-2024)
1.4.3.3 Korea Market States and Outlook (2014-2024)
1.4.3.4 India Market States and Outlook (2014-2024)
1.4.3.5 Southeast Asia Market States and Outlook (2014-2024)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2014-2024)
1.4.4.2 Egypt Market States and Outlook (2014-2024)
1.4.4.3 Saudi Arabia Market States and Outlook (2014-2024)
1.4.4.4 South Africa Market States and Outlook (2014-2024)
1.4.4.5 Turkey Market States and Outlook (2014-2024)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Merck
2.1.1 Business Overview
2.1.2 Pembrolizumab Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Merck Pembrolizumab Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
3 Global Pembrolizumab Sales, Revenue, Market Share and Competition by Manufacturer (2017-2018)
3.1 Global Pembrolizumab Sales and Market Share by Manufacturer (2017-2018)
3.2 Global Pembrolizumab Revenue and Market Share by Manufacturer (2017-2018)
3.3 Market Concentration Rate
3.3.1 Top 3 Pembrolizumab Manufacturer Market Share in 2018
3.3.2 Top 6 Pembrolizumab Manufacturer Market Share in 2018
3.4 Market Competition Trend
4 Global Pembrolizumab Market Analysis by Regions
4.1 Global Pembrolizumab Sales, Revenue and Market Share by Regions
4.1.1 Global Pembrolizumab Sales and Market Share by Regions (2014-2019)
4.1.2 Global Pembrolizumab Revenue and Market Share by Regions (2014-2019)
4.2 North America Pembrolizumab Sales and Growth Rate (2014-2019)
4.3 Europe Pembrolizumab Sales and Growth Rate (2014-2019)
4.4 Asia-Pacific Pembrolizumab Sales and Growth Rate (2014-2019)
4.5 South America Pembrolizumab Sales and Growth Rate (2014-2019)
4.6 Middle East and Africa Pembrolizumab Sales and Growth Rate (2014-2019)
5 North America Pembrolizumab by Country
5.1 North America Pembrolizumab Sales, Revenue and Market Share by Country
5.1.1 North America Pembrolizumab Sales and Market Share by Country (2014-2019)
5.1.2 North America Pembrolizumab Revenue and Market Share by Country (2014-2019)
5.2 United States Pembrolizumab Sales and Growth Rate (2014-2019)
5.3 Canada Pembrolizumab Sales and Growth Rate (2014-2019)
5.4 Mexico Pembrolizumab Sales and Growth Rate (2014-2019)
6 Europe Pembrolizumab by Country
6.1 Europe Pembrolizumab Sales, Revenue and Market Share by Country
6.1.1 Europe Pembrolizumab Sales and Market Share by Country (2014-2019)
6.1.2 Europe Pembrolizumab Revenue and Market Share by Country (2014-2019)
6.2 Germany Pembrolizumab Sales and Growth Rate (2014-2019)
6.3 UK Pembrolizumab Sales and Growth Rate (2014-2019)
6.4 France Pembrolizumab Sales and Growth Rate (2014-2019)
6.5 Russia Pembrolizumab Sales and Growth Rate (2014-2019)
6.6 Italy Pembrolizumab Sales and Growth Rate (2014-2019)
7 Asia-Pacific Pembrolizumab by Country
7.1 Asia-Pacific Pembrolizumab Sales, Revenue and Market Share by Country
7.1.1 Asia-Pacific Pembrolizumab Sales and Market Share by Country (2014-2019)
7.1.2 Asia-Pacific Pembrolizumab Revenue and Market Share by Country (2014-2019)
7.2 China Pembrolizumab Sales and Growth Rate (2014-2019)
7.3 Japan Pembrolizumab Sales and Growth Rate (2014-2019)
7.4 Korea Pembrolizumab Sales and Growth Rate (2014-2019)
7.5 India Pembrolizumab Sales and Growth Rate (2014-2019)
7.6 Southeast Asia Pembrolizumab Sales and Growth Rate (2014-2019)
8 South America Pembrolizumab by Country
8.1 South America Pembrolizumab Sales, Revenue and Market Share by Country
8.1.1 South America Pembrolizumab Sales and Market Share by Country (2014-2019)
8.1.2 South America Pembrolizumab Revenue and Market Share by Country (2014-2019)
8.2 Brazil Pembrolizumab Sales and Growth Rate (2014-2019)
8.3 Argentina Pembrolizumab Sales and Growth Rate (2014-2019)
8.4 Colombia Pembrolizumab Sales and Growth Rate (2014-2019)
9 Middle East and Africa Pembrolizumab by Countries
9.1 Middle East and Africa Pembrolizumab Sales, Revenue and Market Share by Country
9.1.1 Middle East and Africa Pembrolizumab Sales and Market Share by Country (2014-2019)
9.1.2 Middle East and Africa Pembrolizumab Revenue and Market Share by Country (2014-2019)
9.2 Saudi Arabia Pembrolizumab Sales and Growth Rate (2014-2019)
9.3 Turkey Pembrolizumab Sales and Growth Rate (2014-2019)
9.4 Egypt Pembrolizumab Sales and Growth Rate (2014-2019)
9.5 Nigeria Pembrolizumab Sales and Growth Rate (2014-2019)
9.6 South Africa Pembrolizumab Sales and Growth Rate (2014-2019)
10 Global Pembrolizumab Market Segment by Type
10.1 Global Pembrolizumab Sales, Revenue and Market Share by Type (2014-2019)
10.1.1 Global Pembrolizumab Sales and Market Share by Type (2014-2019)
10.1.2 Global Pembrolizumab Revenue and Market Share by Type (2014-2019)
10.2 50mg Injection Sales Growth and Price
10.2.1 Global 50mg Injection Sales Growth (2014-2019)
10.2.2 Global 50mg Injection Price (2014-2019)
10.3 100mg Injection Sales Growth and Price
10.3.1 Global 100mg Injection Sales Growth (2014-2019)
10.3.2 Global 100mg Injection Price (2014-2019)
11 Global Pembrolizumab Market Segment by Application
11.1 Global Pembrolizumab Sales Market Share by Application (2014-2019)
11.2 Advanced Melanoma Sales Growth (2014-2019)
11.3 Head and Neck Squamous Cell Carcinoma (HNSCC) Sales Growth (2014-2019)
11.4 Unresectable or Metastatic Solid Tumor Sales Growth (2014-2019)
11.5 Other Sales Growth (2014-2019)
12 Pembrolizumab Market Forecast (2019-2024)
12.1 Global Pembrolizumab Sales, Revenue and Growth Rate (2019-2024)
12.2 Pembrolizumab Market Forecast by Regions (2019-2024)
12.2.1 North America Pembrolizumab Market Forecast (2019-2024)
12.2.2 Europe Pembrolizumab Market Forecast (2019-2024)
12.2.3 Asia-Pacific Pembrolizumab Market Forecast (2019-2024)
12.2.4 South America Pembrolizumab Market Forecast (2019-2024)
12.2.5 Middle East and Africa Pembrolizumab Market Forecast (2019-2024)
12.3 Pembrolizumab Market Forecast by Type (2019-2024)
12.3.1 Global Pembrolizumab Sales Forecast by Type (2019-2024)
12.3.2 Global Pembrolizumab Market Share Forecast by Type (2019-2024)
12.4 Pembrolizumab Market Forecast by Application (2019-2024)
12.4.1 Global Pembrolizumab Sales Forecast by Application (2019-2024)
12.4.2 Global Pembrolizumab Market Share Forecast by Application (2019-2024)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
Figure Pembrolizumab Picture
Table Product Specifications of Pembrolizumab
Figure Global Sales Market Share of Pembrolizumab by Types in 2018
Table Pembrolizumab Types for Major Manufacturers
Figure 50mg Injection Picture
Figure 100mg Injection Picture
Figure Pembrolizumab Sales Market Share by Applications in 2018
Figure Advanced Melanoma Picture
Figure Head and Neck Squamous Cell Carcinoma (HNSCC) Picture
Figure Unresectable or Metastatic Solid Tumor Picture
Figure Other Picture
Figure United States Pembrolizumab Revenue (Value) and Growth Rate (2014-2024)
Figure Canada Pembrolizumab Revenue (Value) and Growth Rate (2014-2024)
Figure Mexico Pembrolizumab Revenue (Value) and Growth Rate (2014-2024)
Figure Germany Pembrolizumab Revenue (Value) and Growth Rate (2014-2024)
Figure France Pembrolizumab Revenue (Value) and Growth Rate (2014-2024)
Figure UK Pembrolizumab Revenue (Value) and Growth Rate (2014-2024)
Figure Russia Pembrolizumab Revenue (Value) and Growth Rate (2014-2024)
Figure Italy Pembrolizumab Revenue (Value) and Growth Rate (2014-2024)
Figure China Pembrolizumab Revenue (Value) and Growth Rate (2014-2024)
Figure Japan Pembrolizumab Revenue (Value) and Growth Rate (2014-2024)
Figure Korea Pembrolizumab Revenue (Value) and Growth Rate (2014-2024)
Figure India Pembrolizumab Revenue (Value) and Growth Rate (2014-2024)
Figure Southeast Asia Pembrolizumab Revenue (Value) and Growth Rate (2014-2024)
Figure Brazil Pembrolizumab Revenue (Value) and Growth Rate (2014-2024)
Figure Egypt Pembrolizumab Revenue (Value) and Growth Rate (2014-2024)
Figure Saudi Arabia Pembrolizumab Revenue (Value) and Growth Rate (2014-2024)
Figure South Africa Pembrolizumab Revenue (Value) and Growth Rate (2014-2024)
Figure Nigeria Pembrolizumab Revenue (Value) and Growth Rate (2014-2024)
Table Merck Basic Information, Manufacturing Base and Competitors
Table Merck Pembrolizumab Type and Applications
Table Merck Pembrolizumab Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Global Pembrolizumab Sales by Manufacturer (2017-2018)
Figure Global Pembrolizumab Sales Market Share by Manufacturer in 2017
Figure Global Pembrolizumab Sales Market Share by Manufacturer in 2018
Table Global Pembrolizumab Revenue by Manufacturer (2017-2018)
Figure Global Pembrolizumab Revenue Market Share by Manufacturer in 2017
Figure Global Pembrolizumab Revenue Market Share by Manufacturer in 2018
Figure Top 3 Pembrolizumab Manufacturer (Revenue) Market Share in 2018
Figure Top 6 Pembrolizumab Manufacturer (Revenue) Market Share in 2018
Figure Global Pembrolizumab Sales and Growth Rate (2014-2019)
Figure Global Pembrolizumab Revenue and Growth Rate (2014-2019)
Table Global Pembrolizumab Sales by Regions (2014-2019)
Table Global Pembrolizumab Sales Market Share by Regions (2014-2019)
Table Global Pembrolizumab Revenue by Regions (2014-2019)
Figure Global Pembrolizumab Revenue Market Share by Regions (2014-2019)
Figure Global Pembrolizumab Revenue Market Share by Regions in 2018
Figure North America Pembrolizumab Sales and Growth Rate (2014-2019)
Figure Europe Pembrolizumab Sales and Growth Rate (2014-2019)
Figure Asia-Pacific Pembrolizumab Sales and Growth Rate (2014-2019)
Figure South America Pembrolizumab Sales and Growth Rate (2014-2019)
Figure Middle East and Africa Pembrolizumab Sales and Growth Rate (2014-2019)
Figure North America Pembrolizumab Revenue and Growth Rate (2014-2019)
Table North America Pembrolizumab Sales by Countries (2014-2019)
Table North America Pembrolizumab Sales Market Share by Countries (2014-2019)
Figure North America Pembrolizumab Sales Market Share by Countries (2014-2019)
Figure North America Pembrolizumab Sales Market Share by Countries in 2018
Table North America Pembrolizumab Revenue by Countries (2014-2019)
Table North America Pembrolizumab Revenue Market Share by Countries (2014-2019)
Figure North America Pembrolizumab Revenue Market Share by Countries (2014-2019)
Figure North America Pembrolizumab Revenue Market Share by Countries in 2018
Figure United States Pembrolizumab Sales and Growth Rate (2014-2019)
Figure Canada Pembrolizumab Sales and Growth Rate (2014-2019)
Figure Mexico Pembrolizumab Sales and Growth Rate (2014-2019)
Figure Europe Pembrolizumab Revenue and Growth Rate (2014-2019)
Table Europe Pembrolizumab Sales by Countries (2014-2019)
Table Europe Pembrolizumab Sales Market Share by Countries (2014-2019)
Table Europe Pembrolizumab Revenue by Countries (2014-2019)
Figure Europe Pembrolizumab Revenue Market Share by Countries (2014-2019)
Figure Europe Pembrolizumab Revenue Market Share by Countries in 2018
Figure Germany Pembrolizumab Sales and Growth Rate (2014-2019)
Figure UK Pembrolizumab Sales and Growth Rate (2014-2019)
Figure France Pembrolizumab Sales and Growth Rate (2014-2019)
Figure Russia Pembrolizumab Sales and Growth Rate (2014-2019)
Figure Italy Pembrolizumab Sales and Growth Rate (2014-2019)
Figure Asia-Pacific Pembrolizumab Revenue and Growth Rate (2014-2019)
Table Asia-Pacific Pembrolizumab Sales by Countries (2014-2019)
Table Asia-Pacific Pembrolizumab Sales Market Share by Countries (2014-2019)
Figure Asia-Pacific Pembrolizumab Sales Market Share by Countries 2018
Table Asia-Pacific Pembrolizumab Revenue by Countries (2014-2019)
Figure Asia-Pacific Pembrolizumab Revenue Market Share by Countries 2018
Figure China Pembrolizumab Sales and Growth Rate (2014-2019)
Figure Japan Pembrolizumab Sales and Growth Rate (2014-2019)
Figure Korea Pembrolizumab Sales and Growth Rate (2014-2019)
Figure India Pembrolizumab Sales and Growth Rate (2014-2019)
Figure Southeast Asia Pembrolizumab Sales and Growth Rate (2014-2019)
Figure South America Pembrolizumab Revenue and Growth Rate (2014-2019)
Table South America Pembrolizumab Sales by Countries (2014-2019)
Table South America Pembrolizumab Sales Market Share by Countries (2014-2019)
Figure South America Pembrolizumab Sales Market Share by Countries in 2018
Table South America Pembrolizumab Revenue by Countries (2014-2019)
Table South America Pembrolizumab Revenue Market Share by Countries (2014-2019)
Figure South America Pembrolizumab Revenue Market Share by Countries in 2018
Figure Brazil Pembrolizumab Sales and Growth Rate (2014-2019)
Figure Argentina Pembrolizumab Sales and Growth Rate (2014-2019)
Figure Colombia Pembrolizumab Sales and Growth Rate (2014-2019)
Figure Middle East and Africa Pembrolizumab Revenue and Growth Rate (2014-2019)
Table Middle East and Africa Pembrolizumab Sales by Countries (2014-2019)
Table Middle East and Africa Pembrolizumab Sales Market Share by Countries (2014-2019)
Figure Middle East and Africa Pembrolizumab Sales Market Share by Countries in 2018
Table Middle East and Africa Pembrolizumab Revenue by Countries (2014-2019)
Table Middle East and Africa Pembrolizumab Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Pembrolizumab Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Pembrolizumab Revenue Market Share by Countries in 2018
Figure Saudi Arabia Pembrolizumab Sales and Growth Rate (2014-2019)
Figure UAE Pembrolizumab Sales and Growth Rate (2014-2019)
Figure Egypt Pembrolizumab Sales and Growth Rate (2014-2019)
Figure Nigeria Pembrolizumab Sales and Growth Rate (2014-2019)
Figure South Africa Pembrolizumab Sales and Growth Rate (2014-2019)
Table Global Pembrolizumab Sales by Type (2014-2019)
Table Global Pembrolizumab Sales Share by Type (2014-2019)
Table Global Pembrolizumab Revenue by Type (2014-2019)
Table Global Pembrolizumab Revenue Share by Type (2014-2019)
Figure Global 50mg Injection Sales Growth (2014-2019)
Figure Global 50mg Injection Price (2014-2019)
Figure Global 100mg Injection Sales Growth (2014-2019)
Figure Global 100mg Injection Price (2014-2019)
Table Global Pembrolizumab Sales by Application (2014-2019)
Table Global Pembrolizumab Sales Share by Application (2014-2019)
Figure Global Head and Neck Squamous Cell Carcinoma (HNSCC) Sales Growth (2014-2019)
Figure Global Unresectable or Metastatic Solid Tumor Sales Growth (2014-2019)
Figure Global Other Sales Growth (2014-2019)
Figure Global Pembrolizumab Sales, Revenue and Growth Rate (2019-2024)
Table Global Pembrolizumab Sales Forecast by Regions (2019-2024)
Table Global Pembrolizumab Market Share Forecast by Regions (2019-2024)
Figure North America Sales Pembrolizumab Market Forecast (2019-2024)
Figure Europe Sales Pembrolizumab Market Forecast (2019-2024)
Figure Asia-Pacific Sales Pembrolizumab Market Forecast (2019-2024)
Figure South America Sales Pembrolizumab Market Forecast (2019-2024)
Figure Middle East and Africa Sales Pembrolizumab Market Forecast (2019-2024)
Table Global Pembrolizumab Sales Forecast by Type (2019-2024)
Table Global Pembrolizumab Market Share Forecast by Type (2019-2024)
Table Global Pembrolizumab Sales Forecast by Application (2019-2024)
Table Global Pembrolizumab Market Share Forecast by Application (2019-2024)
Table Distributors/Traders/ Dealers List
世界の頭頸部治療の扁平上皮がん市場：市場規模・現状・予測 Head and neck cancer usually occurs in the squamous cells present inside the mouth, nose and throat. These squamous cells are usually known as squamous cell carcinoma of the head and neck.In 2018, the global Squamous Cell Carcinoma of the Head and Neck Treatment market size was xx million US$ and it…- ニボルマブの世界市場予測 2024年：メーカー別、地域別、種類・用途別（～2024） Scope of the Report: The worldwide market for Nivolumab is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study. This report focuses on the Nivolumab in global market, e…
- デュルバルマブの世界市場予測 2024年：メーカー別、地域別、種類・用途別（～2024） Scope of the Report: The worldwide market for Durvalumab is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study. This report focuses on the Durvalumab in global market,…
- 世界の転移性ぶどう膜黒色腫市場2019 The global Metastatic Uveal Melanoma Thereapeutics market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report studies the global Metastatic Uveal Melanoma Thereapeutics market status and forecast, categorizes the global …
- 注入式マスターバッチ市場：世界及び中国の市場分析・予測（～2024年） Advanced Injection Masterbatch Market Insights 2019, Global and Chinese Scenario is a professional and in-depth study on the current state of the global Advanced Injection Masterbatch industry with a focus on the Chinese market. The report provides key statistics on the market status of the Advanced…